Screening and Identification of Potential Hub Genes in Myocardial Infarction Through Bioinformatics Analysis

References

• Lopez A, Mathers C, Ezzati M, Jamison D, Murray C. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–1757. doi:10.1016/S0140-6736(06)68770-916731270
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Benjamin E, Go A, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38–360.26673558
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177.28886621
   PubMed Web of Science ®Google Scholar
• Rao S, Kaul P, Newby L, et al. Poverty, process of care, and outcome in acute coronary syndromes. J Am Coll Cardiol. 2003;41(11):1948–1954. doi:10.1016/S0735-1097(03)00402-912798563
   PubMed Web of Science ®Google Scholar
• Xia J, Wu H, Lai B, et al. Gene delivery of hypoxia-inducible VEGF targeting collagen effectively improves cardiac function after myocardial infarction. Sci Rep. 2017;7(1):13273. doi:10.1038/s41598-017-13547-129038511
   PubMed Web of Science ®Google Scholar
• Rieckmann M, Delgobo M, Gaal C, et al. Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses. J Clin Invest. 2019;129(11):4922–4936. doi:10.1172/JCI12385931408441
   PubMed Web of Science ®Google Scholar
• Galiuto L, DeMaria A, Iliceto S. Microvascular damage during myocardial ischemia-reperfusion: pathophysiology, clinical implications and potential therapeutic approach evaluated by myocardial contrast echocardiography. Ital Heart J. 2000;1(2):108–116.10730610
   PubMedGoogle Scholar
• Eefting F, Rensing B, Wigman J, et al. Role of apoptosis in reperfusion injury. Cardiovasc Res. 2004;61(3):414–426. doi:10.1016/j.cardiores.2003.12.02314962473
   PubMed Web of Science ®Google Scholar
• Mathur A, Martin J. Stem cells and repair of the heart. Lancet. 2004;364(9429):183–192. doi:10.1016/S0140-6736(04)16632-415246732
   PubMed Web of Science ®Google Scholar
• Huang K, Wang J, Zhou Y, et al. Antithrombin III alleviates myocardial ischemia/reperfusion injury by inhibiting excessive autophagy in a phosphoinositide 3-Kinase/Akt-dependent manner. Front Pharmacol. 2019;10:516. doi:10.3389/fphar.2019.0051631133861
   PubMed Web of Science ®Google Scholar
• Zeng J, Jin Q, Ruan Y, et al. Inhibition of TGFβ-activated protein kinase 1 ameliorates myocardial ischaemia/reperfusion injury via endoplasmic reticulum stress suppression. J Cell Mol Med. 2020;24(12):6846–6859. doi:10.1111/jcmm.1534032378287
   PubMed Web of Science ®Google Scholar
• Podgoreanu M, White W, Morris R, et al. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation. 2006;114:I275–1281. doi:10.1161/CIRCULATIONAHA.105.00103216820586
   PubMed Web of Science ®Google Scholar
• Devaux Y, Bousquenaud M, Rodius S, et al. Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction. BMC Med Genomics. 2011;4(1):83. doi:10.1186/1755-8794-4-8322136666
   PubMed Web of Science ®Google Scholar
• Kim J, Ghasemzadeh N, Eapen D, et al. Gene expression profiles associated with acute myocardial infarction and risk of cardiovascular death. Genome Med. 2014;6(5):40. doi:10.1186/gm56024971157
   PubMed Web of Science ®Google Scholar
• Lyu J, Wang M, Kang X, et al. Macrophage-mediated regulation of catecholamines in sympathetic neural remodeling after myocardial infarction. Basic Res Cardiol. 2020;115(5):56. doi:10.1007/s00395-020-0813-332767120
   PubMed Web of Science ®Google Scholar
• Hunter C, Jones S. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448–457. doi:10.1038/ni.315325898198
   PubMed Web of Science ®Google Scholar
• Lyngbakken M, Myhre P, Røsjø H, Omland T. Novel biomarkers of cardiovascular disease: applications in clinical practice. Crit Rev Clin Lab Sci. 2019;56(1):33–60.30457415
   PubMed Web of Science ®Google Scholar
• Halade G, Jin Y, Lindsey M. Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. Pharmacol Ther. 2013;139(1):32–40. doi:10.1016/j.pharmthera.2013.03.00923562601
   PubMed Web of Science ®Google Scholar
• Turner N, Porter K. Regulation of myocardial matrix metalloproteinase expression and activity by cardiac fibroblasts. IUBMB Life. 2012;64(2):143–150. doi:10.1002/iub.59422215527
   PubMed Web of Science ®Google Scholar
• Xie Z, Singh M, Singh K. Differential regulation of matrix metalloproteinase-2 and −9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J Biol Chem. 2004;279(38):39513–39519. doi:10.1074/jbc.M40584420015269222
   PubMed Web of Science ®Google Scholar
• Ardi V, Kupriyanova T, Deryugina E, Quigley J. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci U S A. 2007;104(51):20262–20267. doi:10.1073/pnas.070643810418077379
   PubMed Web of Science ®Google Scholar
• Lindsey M, Wedin K, Brown M, et al. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation. 2001;103(17):2181–2187. doi:10.1161/01.CIR.103.17.218111331260
   PubMed Web of Science ®Google Scholar
• Romanic A, Harrison S, Bao W, et al. Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. Cardiovasc Res. 2002;54(3):549–558. doi:10.1016/S0008-6363(02)00254-712031700
   PubMed Web of Science ®Google Scholar
• Kelly D, Cockerill G, Ng L, et al. Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J. 2007;28(6):711–718. doi:10.1093/eurheartj/ehm00317339265
   PubMed Web of Science ®Google Scholar
• Creemers E, Cleutjens J, Smits J, Daemen M. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res. 2001;89(3):201–210. doi:10.1161/hh1501.09439611485970
   PubMed Web of Science ®Google Scholar
• Mauviel A. Cytokine regulation of metalloproteinase gene expression. J Cell Biochem. 1993;53(4):288–295. doi:10.1002/jcb.2405304048300745
   PubMed Web of Science ®Google Scholar
• Lindsey M, Escobar G, Dobrucki L, et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006;290(1):H232–H239. doi:10.1152/ajpheart.00457.200516126817
   PubMed Web of Science ®Google Scholar
• Page-McCaw A, Ewald A, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8(3):221–233. doi:10.1038/nrm212517318226
   PubMed Web of Science ®Google Scholar
• Stefanidakis M, Ruohtula T, Borregaard N, Gahmberg C, Koivunen E. Intracellular and cell surface localization of a complex between alphaMbeta2 integrin and promatrix metalloproteinase-9 progelatinase in neutrophils. J Immunol. 2004;172(11):7060–7068. doi:10.4049/jimmunol.172.11.706015153528
   PubMed Web of Science ®Google Scholar
• Deleon-Pennell K, Altara R, Yabluchanskiy A, Modesti A, Lindsey M. The circular relationship between matrix metalloproteinase-9 and inflammation following myocardial infarction. IUBMB Life. 2015;67(8):611–618. doi:10.1002/iub.140826269290
   PubMed Web of Science ®Google Scholar
• Wagner D, Delagardelle C, Ernens I, Rouy D, Vaillant M, Beissel J. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J Card Fail. 2006;12(1):66–72. doi:10.1016/j.cardfail.2005.08.00216500583
   PubMed Web of Science ®Google Scholar
• Parajuli N, Yuan Y, Zheng X, Bedja D, Cai Z. Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway. Basic Res Cardiol. 2012;107(2):248. doi:10.1007/s00395-012-0248-622298084
   PubMed Web of Science ®Google Scholar
• Bendeck M. Macrophage matrix metalloproteinase-9 regulates angiogenesis in ischemic muscle. Circ Res. 2004;94(2):138–139. doi:10.1161/01.RES.0000117525.23089.1A14764648
   PubMed Web of Science ®Google Scholar
• Xu J, Rodriguez D, Petitclerc E, et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol. 2001;154(5):1069–1079. doi:10.1083/jcb.20010311111535623
   PubMed Web of Science ®Google Scholar
• Johnson C, Sung H, Lessner S, Fini M, Galis Z. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. Circ Res. 2004;94(2):262–268. doi:10.1161/01.RES.0000111527.42357.6214670843
   PubMed Web of Science ®Google Scholar
• DeLeon-Pennell K, de Castro Brás L, Iyer R, et al. P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9. J Mol Cell Cardiol. 2014;76:218–226. doi:10.1016/j.yjmcc.2014.09.00725240641
   PubMed Web of Science ®Google Scholar
• Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159–175.23435331
   PubMed Web of Science ®Google Scholar
• Hori Y, Kunihiro S, Sato S, et al. Doxycycline attenuates isoproterenol-induced myocardial fibrosis and matrix metalloproteinase activity in rats. Biol Pharm Bull. 2009;32(10):1678–1682. doi:10.1248/bpb.32.167819801827
   PubMed Web of Science ®Google Scholar
• Fana X, Zhu H, Wu X, Yan J, Xu J, Wang D. Effects of doxycycline on cx43 distribution and cardiac arrhythmia susceptibility of rats after myocardial infarction. Iran J Pharm Res. 2014;13(2):613–621.25237357
   PubMed Web of Science ®Google Scholar
• Albrengues J, Shields M, Ng D, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science (New York, NY). 2018;361(6409):eaao4227. doi:10.1126/science.aao4227
   Google Scholar
• Herich S, Schneider-Hohendorf T, Rohlmann A, et al. Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis. Brain. 2019;142(11):3411–3427. doi:10.1093/brain/awz30131563951
   PubMed Web of Science ®Google Scholar
• Zhang W, Song J, Zhang X, et al. Salvianolic acid A attenuates ischemia reperfusion induced rat brain damage by protecting the blood brain barrier through MMP-9 inhibition and anti-inflammation. Chin J Nat Med. 2018;16(3):184–193. doi:10.1016/S1875-5364(18)30046-329576054
   PubMed Web of Science ®Google Scholar
• Eghbalzadeh K, Georgi L, Louis T, et al. Compromised anti-inflammatory action of neutrophil extracellular traps in PAD4-deficient mice contributes to aggravated acute inflammation after myocardial infarction. Front Immunol. 2019;10:2313. doi:10.3389/fimmu.2019.0231331632398
   PubMed Web of Science ®Google Scholar
• Huang P, Wang L, Li Q, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020;116(2):353–367.31119268
   PubMed Web of Science ®Google Scholar
• Gray R, Cantwell M, Coleman H, et al. Evaluation of PTGS2 expression, PIK3CA mutation, aspirin use and colon cancer survival in a Population-Based Cohort Study. Clin Transl Gastroenterol. 2017;8(4):e91. doi:10.1038/ctg.2017.1828448072
   PubMed Web of Science ®Google Scholar
• Ge Z, Zhu X, Wang B, et al. MicroRNA-26b relieves inflammatory response and myocardial remodeling of mice with myocardial infarction by suppression of MAPK pathway through binding to PTGS2. Int J Cardiol. 2019;280:152–159. doi:10.1016/j.ijcard.2018.12.07730679074
   PubMed Web of Science ®Google Scholar
• Shirakawa K, Endo J, Kataoka M, et al. IL (interleukin)-10-STAT3-galectin-3 axis is essential for osteopontin-producing reparative macrophage polarization after myocardial infarction. Circulation. 2018;138(18):2021–2035. doi:10.1161/CIRCULATIONAHA.118.03504729967195
   PubMed Web of Science ®Google Scholar
• Morange P, Saut N, Alessi M, et al. Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study. Arterioscler Thromb Vasc Biol. 2007;27(10):2250–2257. doi:10.1161/ATVBAHA.107.14946817656673
   PubMed Web of Science ®Google Scholar
• Xu J, Li W, Bao X, et al. Association of putative functional variants in the PLAU gene and the PLAUR gene with myocardial infarction. Clin Sci. 2010;119(8):353–359. doi:10.1042/CS20100151
   Web of Science ®Google Scholar
• Wang N, Liu C, Wang X, et al. Hyaluronic acid oligosaccharides improve myocardial function reconstruction and angiogenesis against myocardial infarction by regulation of macrophages. Theranostics. 2019;9(7):1980–1992. doi:10.7150/thno.3107331037151
   PubMed Web of Science ®Google Scholar
• Gupta R, Liu L, Zhang X, et al. IL-10 provides cardioprotection in diabetic myocardial infarction via upregulation of Heme clearance pathways. JCI Insight. 2020;5(17). doi:10.1172/jci.insight.133050
   Web of Science ®Google Scholar